Published on: Feb 05, 2018 at Cancer Network

HIPEC Increased Survival in Gastric Cancer With Peritoneal Metastasis

By : Cancer Network

Data shared at ASCO’s Gastrointestinal Cancers Symposium also included research that found hyperthermic intraperitoneal chemotherapy (HIPEC), which delivers chemotherapy directly to cancer cells in the abdomen, increases survival for gastric cancer patients with peritoneal metastasis.

Read More
SHARE